There is no completed head-to-head trial proving one is superior in the same population
Advanced Lab Testing Objective data helps us determine if peptide therapy is right for you and how to optimize it
A 2024 randomised trial found IV glutathione reduced melanin by 18.7% over eight weeks, while oral glutathione at higher cumulative doses reduced melanin by only 3.2%
The neuroprotective effect of AST could be explained by its proven capability to alleviate oxidative stress, improve resistance to the free radicals , attacks 20 that were triggered by FPN and to boost the total antioxidant defenses and regulation of redox homeostasis 89 , which in turn limited oxidative stress-driven neuroinflammation and modulated the immunohistochemical staining of the GFAP, as reported by Ying et al
Mugabo Y, Zhao S, Seifried A, Gezzar S, Al-Mass A, Zhang D, et al